Home / Japan / BrightPath Biotherapeutics Co.,Ltd.

BrightPath Biotherapeutics Co.,Ltd.

Short position disclosed on August 5, 2026.

Evolution of the disclosed total

0%2%4%6%
Aug 4Aug 5Aug 6Aug 7Aug 8Aug 9
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Nomura International plc2.53%newAugust 5, 2026
Barclays Capital Securities Ltd1.61%-0.21 ptAugust 5, 2026
Goldman Sachs International0.41%newAugust 5, 2026

History of disclosures

6 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 5, 2026Nomura International plc2.53%still open
August 5, 2026Barclays Capital Securities Ltd1.61%still open
August 5, 2026Goldman Sachs International0.41%still open
August 4, 2026Barclays Capital Securities Ltd1.76%still open
August 4, 2026Goldman Sachs International0.66%still open
August 3, 2026Barclays Capital Securities Ltd1.82%still open

Other companies sold short in Japan